1. Lack of Efficacy of Probiotics in Preventing Ventilator-Associated Pneumonia 
Wan-Jie Gu, MSc, Chun-Yin Wei, MSc, Rui-Xing Yin, MD, PhD 
CHEST 
Volume 142, Issue 4, Pages (October 2012)
DOI: /chest
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

2. Figure 1
Selection process for RCTs included in the meta-analysis. RCT = randomized controlled trial; VAP = ventilator-associated pneumonia.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

3. Figure 2
Meta-analysis of RCTs evaluating effects of probiotics on the incidence of VAP. There was no significant effect in preventing VAP as determined by the random-effects model. See Figure 1 legend for expansion of abbreviations.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

4. Figure 3
Meta-analysis of RCTs evaluating effects of probiotics on ICU mortality. There was no significant effect on ICU mortality as determined by the random-effects model. See Figure 1 legend for expansion of abbreviation.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions

5. Figure 4
Meta-analysis of RCTs evaluating effects of probiotics on hospital mortality. There was no significant effect on hospital mortality as determined by the random-effects model. See Figure 1 legend for expansion of abbreviation.
CHEST  , DOI: ( /chest )
Copyright © 2012 The American College of Chest Physicians Terms and Conditions